Ironwood Investment Counsel, LLC Biogen Inc. Transaction History

Ironwood Investment Counsel, LLC

  • $569 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 01, 2019
SELL
$216.71 - $338.96 $552,177 - $863,670
-2,548 Closed
0 $0
Q4 2018

Jan 25, 2019
SELL
$278.5 - $352.75 $21,723 - $27,514
-78 Reduced 2.97%
2,548 $766,000
Q3 2018

Oct 23, 2018
BUY
$293.51 - $383.83 $770,757 - $1.01 Million
2,626 New
2,626 $927,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Ironwood Investment Counsel, LLC Portfolio

Follow Ironwood Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Counsel, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email